Literature DB >> 6366064

Improved enzyme immunoassays for the detection of antigens in fecal specimens. Investigation and correction of interfering factors.

R Viscidi, B E Laughon, M Hanvanich, J G Bartlett, R H Yolken.   

Abstract

Solid phase enzyme immunoassays (EIA) are widely used for the detection of infectious agents in body fluids such as stool specimens. However, we found that stool specimens contained substances which desorb from 50% to 68% of the immunoreactant from solid phase surfaces. This desorbing activity decreased the sensitivity of EIA systems for toxin A of C. difficile, rotavirus and adenovirus. The desorbing activity in stool specimens was partially heat labile at 56 degrees C for 30 min, was present in stool fractions corresponding to an estimated molecular weight of 25,000 and was shown to degrade solid phase protein. In addition, the desorbing activity was partially reversed by specific and nonspecific protease inhibitors. Thus, the desorption may reflect the enzymatic activity of stool proteases. The desorption was markedly reduced by diluting specimens in 50% fetal calf serum or an acid-protein buffer such as 0.25 M citrate buffer, pH 4.7, containing 5% bovine serum albumin. These diluents were shown to improve the recovery of toxin A of C. difficile, rotavirus and adenovirus in EIA systems for these antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6366064     DOI: 10.1016/0022-1759(84)90092-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  17 in total

1.  Membrane filtration enzyme immunoassay, a novel, rapid method for measurement of virus-specific immunoglobulins G and M and detection of viral antigens.

Authors:  G R Barnett; G A Tannock; D A Bryce
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

2.  Identification of a group-reactive epitope of group B rotaviruses recognized by monoclonal antibody and application to the development of a sensitive immunoassay for viral characterization.

Authors:  R Yolken; S B Wee; J Eiden; J Kinney; S Vonderfecht
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 3.  Rapid methods for the molecular diagnosis of infectious diseases: current trends and applications.

Authors:  P G Miotti
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

4.  Evaluation of the diagnostic application of an enzyme immunoassay for Clostridium perfringens type A enterotoxin.

Authors:  S G Jackson; D A Yip-Chuck; M H Brodsky
Journal:  Appl Environ Microbiol       Date:  1986-10       Impact factor: 4.792

5.  Time-resolved fluoroimmunoassay for enteric adenoviruses using the europium chelator 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid.

Authors:  M Brown; Y Shami; M Zywulko; N Singh-Naz; P J Middleton
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 6.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  New methods for the diagnosis of enteric infections.

Authors:  R H Yolken
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

8.  Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

9.  Coproantigens in gut tapeworm infections: Hymenolepis diminuta in rats.

Authors:  J C Allan; P S Craig
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

10.  Detection of Clostridium difficile toxins by enzyme immunoassay.

Authors:  C Krishnan
Journal:  J Hyg (Lond)       Date:  1986-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.